欧林生物
(688319)
| 流通市值：111.04亿 | | | 总市值：111.19亿 |
| 流通股本：4.05亿 | | | 总股本：4.06亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 169,670,167.26 | 184,322,268.85 | 191,476,245.44 | 224,158,718.94 |
| 交易性金融资产 | 47,600,000 | 17,600,000 | 22,600,000 | 17,500,000 |
| 应收票据及应收账款 | 665,082,511.8 | 617,274,832.43 | 555,335,585.58 | 570,352,146.84 |
| 其中：应收票据 | 168,000 | 160,800 | 3,662,084.03 | 3,931,504.03 |
| 应收账款 | 664,914,511.8 | 617,114,032.43 | 551,673,501.55 | 566,420,642.81 |
| 预付款项 | 9,384,798.72 | 8,961,806.4 | 5,947,422.33 | 9,109,909.72 |
| 其他应收款合计 | 2,623,482.62 | 2,344,537.99 | 2,018,317.37 | 1,002,780.71 |
| 存货 | 68,803,356.79 | 76,037,389.4 | 85,147,611.63 | 85,681,980.63 |
| 其他流动资产 | 1,059,401.37 | 1,662,731.38 | 1,953,408.36 | 338,231.58 |
| 流动资产合计 | 964,223,718.56 | 908,203,566.45 | 864,478,590.71 | 908,143,768.42 |
| 非流动资产: | | | | |
| 固定资产 | 390,396,357.92 | 366,904,216.12 | 364,288,189.66 | 359,496,159.66 |
| 在建工程 | 200,612,663.22 | 217,503,452.63 | 217,036,543.13 | 211,268,782.79 |
| 使用权资产 | 12,476,293.36 | 10,939,570.96 | 615,931.15 | 1,539,827.93 |
| 无形资产 | 17,242,138.35 | 17,581,416.83 | 16,029,636.95 | 16,330,201.53 |
| 开发支出 | 330,915,866.8 | 289,366,717.64 | 285,288,006.29 | 282,893,478.39 |
| 长期待摊费用 | 5,809,678.74 | 6,836,586.34 | 7,868,559.93 | 8,604,170.41 |
| 递延所得税资产 | 22,715,457.93 | 18,206,740.39 | 18,206,740.39 | 18,206,740.39 |
| 其他非流动资产 | 577,465 | 691,823.5 | 218,000 | 560,280 |
| 非流动资产合计 | 980,745,921.32 | 928,030,524.41 | 909,551,607.5 | 898,899,641.1 |
| 资产总计 | 1,944,969,639.88 | 1,836,234,090.86 | 1,774,030,198.21 | 1,807,043,409.52 |
| 流动负债: | | | | |
| 短期借款 | 20,000,000 | 20,000,000 | 19,200,000 | 24,200,000 |
| 应付票据及应付账款 | 116,333,283.38 | 86,434,331.35 | 79,866,745.99 | 86,291,934.08 |
| 应付账款 | 116,333,283.38 | 86,434,331.35 | 79,866,745.99 | 86,291,934.08 |
| 合同负债 | 2,115,824.76 | 622,059.22 | 2,025,587.38 | 510,853.4 |
| 应付职工薪酬 | 434,378 | 425,203.95 | 426,394.51 | 15,196,149.64 |
| 应交税费 | 9,116,387.4 | 5,857,039.16 | 8,260,158.88 | 13,759,748.92 |
| 其他应付款合计 | 405,672,924.18 | 383,476,126.74 | 347,106,925.55 | 368,199,529.27 |
| 一年内到期的非流动负债 | 78,698,512.22 | 65,950,965.17 | 81,350,000 | 87,420,000 |
| 其他流动负债 | 18,032.24 | 18,661.78 | 60,767.62 | 15,325.6 |
| 流动负债合计 | 632,389,342.18 | 562,784,387.37 | 538,296,579.93 | 595,593,540.91 |
| 非流动负债: | | | | |
| 长期借款 | 289,331,528.4 | 304,241,528.4 | 278,501,528.4 | 249,531,528.4 |
| 租赁负债 | 8,646,041.99 | 7,343,844.31 | 656,852.67 | 639,082 |
| 预计负债 | 11,653,604.32 | 1,736,448.67 | 744,706.38 | 532,181.34 |
| 递延收益 | 26,354,964.63 | 23,249,309.02 | 25,002,055.84 | 24,786,106.63 |
| 递延所得税负债 | 8,255,815.87 | 2,458,748.62 | 2,458,748.62 | 2,458,748.62 |
| 非流动负债合计 | 344,241,955.21 | 339,029,879.02 | 307,363,891.91 | 277,947,646.99 |
| 负债合计 | 976,631,297.39 | 901,814,266.39 | 845,660,471.84 | 873,541,187.9 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 405,933,600 | 405,933,600 | 405,933,600 | 405,933,600 |
| 资本公积 | 593,690,397.97 | 593,690,397.97 | 607,911,623.63 | 606,002,585.54 |
| 减:库存股 | 5,561,325 | 5,561,325 | 5,561,325 | 5,561,325 |
| 盈余公积 | 14,198,275.26 | 14,198,275.26 | 14,198,275.26 | 14,198,275.26 |
| 未分配利润 | -48,414,233.4 | -82,697,109.91 | -102,967,913.16 | -95,894,001.38 |
| 归属于母公司股东权益合计 | 959,846,714.83 | 925,563,838.32 | 919,514,260.73 | 924,679,134.42 |
| 少数股东权益 | 8,491,627.66 | 8,855,986.15 | 8,855,465.64 | 8,823,087.2 |
| 股东权益合计 | 968,338,342.49 | 934,419,824.47 | 928,369,726.37 | 933,502,221.62 |
| 负债和股东权益合计 | 1,944,969,639.88 | 1,836,234,090.86 | 1,774,030,198.21 | 1,807,043,409.52 |
| 公告日期 | 2025-10-30 | 2025-08-29 | 2025-04-26 | 2025-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |